Study of the safety and efficacy of ACE inhibitors and their effects on 24-hour electrocardiographic monitoring in the treatment of moderate-to-severe heart failure: an interim analysis.
Adgey
J
J
Department of Cardiology, Royal Victoria Hospital, Belfast, Northern Ireland.
Clarke
M
M
Raza
A
A
Meddis
D
D
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D004151:Dipeptides / Q000627:therapeutic use*; D004311:Double-Blind Method; D015716:Electrocardiography, Ambulatory / Q000187:drug effects*; D004656:Enalapril / Q000627:therapeutic use*; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D017706:Lisinopril; D008297:Male; D008875:Middle Aged; D013318:Stroke Volume / Q000187:drug effects; D017180:Tachycardia, Ventricular / Q000517:prevention & control; D016277:Ventricular Function, Left / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D004151:Dipeptides; D004656:Enalapril; D017706:Lisinopril